Page 63 - Sohini Das

Our Caribbean ops bring us close to US mkt: Narayana Health's Viren Shetty

In a Q&A, the executive vice-chairman of the hospital chain dwells on lessons from the pandemic, says hospital industry has always been dollar-exposed and thus had pressure on margins

India sitting on 500 million syringe inventory as demand goes down

The government has also cancelled several orders of various manufacturers giving quality reasons

Expert panel approves use of Serum Institute's Covovax for 7-11-year olds

India started vaccinating adolescents (aged 15-18) from January, and further expanded the drive to include children as young as 12 years from March

Dr Reddy's Laboratories eyes place among top five domestic pharma players

The US would continue to remain an important geography, but the firm says it hopes to double its revenues from China and grow revenues five-fold in Brazil in the next five years

Step up Covid-19 testing and genome sequencing: Mansukh Mandaviya

India reported 13,313 new cases in the last 24 hours and the active caseload currently stands at 83,990

18% people in India reinfected with Covid-19 in last 6 months: Survey

Around 46 per cent of those surveyed said their second infection was more severe than the first one

Our goal is to have HPV vaccination as part of State mission: MSD India MD

In a Q&A, Rehan A Khan talks about his firm's strong focus on R&D and its commitment to making drugs affordable

CBI arrests Jt Drug Controller, Biocon Biologics execs over fishy approvals

All five apprehended will be presented in court on Tuesday afternoon, agency to seek police custody

SEC recommendation in accordance with guidelines: Biocon Biologics

The company said its product approvals are backed by science and clinical data

Fewer deaths, more hospitalisations in metros amid the spike in cases

Large cities are seeing an increase in occupancy, though most beds still remain vacant

Bharat Biotech's Covaxin induces wider immune response, say experts

However, experts say that Covaxin induces a wider immune response and thus antibody production against the spike protein may be less intense

Covishield booster post Covaxin priming improves immune response 58x: CMC

So far, India has not allowed heterologous boosting of vaccines

Price rationalisation, consolidation likely in Indian diagnostic space

Competitive pricing, however, is here to stay, feel analysts and some industry insiders

WTO's vaccine patent waiver may have little impact on ground now: Industry

Serum Institute says while patent waivers for Covid-19 vaccines are 'encouraging', demand for vaccines today is declining

Bharat Biotech's Covaxin is safe for children between 2 and 18 yrs: Lancet

Data from over 50 million doses reveals minimal side effects

Glenmark drug for treating uncontrolled asthma gets Indian regulator's nod

Company says treatment will be affordable and improve lung function of patients

Top 300 drug brands to have QR codes on label for ensuring authenticity

The Union Ministry of Health has made amendments to the Drugs Rules, 1945, to implement this

Vaccine makers claims efficacy against Omicron variant of Covid-19

Omicron has been the dominant strain across the world since January, quickly replacing the Delta variant that had caused a devastating second wave in India

Lots of interest in Metropolis, but we want a strategic fit: MD Ameera Shah

In a Q&A, the promoter and MD of the company talks about how the dynamics are changing in the diagnostics sector post Covid, and outlines her strategy for Metropolis 3.0

No plans to exit business, says Metropolis Healthcare promoters

"The company, its promoters and management team are committed to operating Metropolis Healthcare Ltd with the highest standards of medical science, stakeholder trust and customer engagement," the comp